Overview

Elevate Cardiovascular Care with Precision Pharmacogenomics

Optimize treatments for every heart patient, reduce complications, and improve quality metrics across your health system.

Schedule a Demo Contact us

Overview

Cardiovascular diseases demand precise and personalized interventions. PGxAI's Cardiology module (PGxPulsar™) leverages advanced pharmacogenomics and real-world data analytics to deliver individualized treatment recommendations. By integrating genetic markers and clinical parameters, our platform reduces trial-and-error prescribing, mitigates adverse events, and enhances therapeutic outcomes for conditions ranging from hypertension to heart failure.

•

100+ cardiovascular drugs under coverage, including anticoagulants, beta-blockers, ACE inhibitors, and statins.

•

56 key genetic markers analyzed for drug-gene interactions crucial to cardiology.

•

Generative AI that updates recommendations in real-time, maximizing efficacy while minimizing side effects.

Key Highlights

Serving every stakeholder in healthcare

Schedule a Demo Contact Us

Comprehensive Drug-Gene Database

Analyzes critical genes like CYP2C9, VKORC1, and SLCO1B1, influencing response to warfarin, statins, and more.

Reduced Hospital Readmissions

Personalized dosing and drug selection help lower bleeding events, suboptimal therapy, and ER visits.

Real-World Evidence

Continuous learning from clinical outcomes ensures data-backed confidence for your cardiology team.

Reimbursement Pathways

Most PGx tests align with established CPT codes, simplifying billing and reinforcing cost-effectiveness.

Clinical Impact

Maximize Clinical Impact with PGxAI

Schedule a Demo Contact Us

Precision-Guided Therapy Optimization

PGxAI mines genotype, phenotype, and comorbidity data in real time to recommend the optimal drug–dose pair at the first prescription. By accounting for actionable allelic variants and metabolic phenotypes, it minimizes trial-and-error titration and sharply reduces severe drug–gene and drug–drug interactions.

Superior Patient Outcomes & Experience

Genomically informed prescribing lowers adverse-event rates, accelerates therapeutic response, optimizes co-administered medications and boosts adherence. Patients spend less time managing side effects and more time benefiting from treatment, enhancing both clinical endpoints and satisfaction metrics across specialties.

Demonstrable Value-Based Performance

Fewer complications, shorter lengths of stay, and reduced readmissions translate into measurable gains on CMS and private-payer quality dashboards. Institutions leveraging PGxAI can document higher quality scores and capture value-based reimbursement upside while lowering total cost of care.

Seamless Team Integration & Scalability

The platform embeds directly into leading EHRs and e-prescribing systems, delivering concise, guideline-aligned reports that support rapid decision-making for multidisciplinary teams. Standardized APIs and CDS hooks allow effortless expansion from pilot units to enterprise-wide deployment without workflow disruption.

Drug Categories

PGxAI supports a wide array of cardiovascular therapies

Schedule a Demo Contact Us